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144
Gai:β-arrestin:V2R complexes form at the plasma membrane
145
We then visualized colocalization of Gai, β-arrestin, and V2R using confocal microscopy 146 (Fig. 2a) . We validated the imaging parameters using single-colour controls to ensure accurate 147 quantification of each component channel (Extended Data Fig. 4) . Colocalization of Gai, β-arrestin,
148
and V2R occurred after agonist treatment and was most prominent at the plasma membrane. Line 149 scan analyses demonstrated plasma membrane-localized puncta consisting of each megaplex 150 component after 5 minutes of agonist treatment (Fig. 2b,c) . Thirty minutes after agonist treatment,
151
clear endosomal β-arrestin:V2R colocalization was observed that lacked substantial Gai (Fig. 2d ).
152
These observations suggest that formation of Gai:β-arrestin:V2R megaplexes occurs after agonist 153 treatment and is most prominent at the plasma membrane. 
Gai forms a complex with β-arrestin following GPCR agonist treatment
165
The difference in magnitude of signal observed in complex BRET between Gai and Gas 
169
We therefore hypothesized that other critical interactions between G proteins and b-arrestins 170 could be catalysed by agonist treatment of the V2R. We confirmed that the V2R primarily signals 171 via Gas (Fig. 3a) and recruits b-arrestin (Fig. 3b) following agonist treatment. Notably, V2R did not
172
canonically signal via Gai, even under these overexpressed conditions (Fig. 3a) . Similarly, we 173 observed predominant Gas signalling and b-arrestin recruitment at the β2AR, another canonically
174
Gas-coupled receptor (Extended data Fig 5a,b) .
176
We proceeded to interrogate the formation of G protein and b-arrestin scaffolds using split 177 luciferase technology 9 (nanoBiT) by fusing the smaller subunit (smBiT) of the split luciferase to β-
178
arrestin-2 and inserting the larger subunit (LgBiT) into a similar location in the four primary Ga 179 families, Gas, Gai, Gaq, and Ga12. In direct contrast with the Ga protein signalling, only Gai, but not 
199
Gas, Gaq or Ga12, formed an observable complex with β-arrestin following V2R treatment with AVP
200
( Fig. 3d) . Given that the V2R is not canonically known to signal through Gai, this was surprising,
201
especially given the absence of Gai signalling in our assay. Varying the amounts of Ga subunit
202
transfected by up to 10-fold did not increase the interaction between non-Gai family members and 203 β-arrestin following agonist treatment of either the V2R or β2AR (Extended Data Fig. 6a-h ).
204
Furthermore, Gai isoforms 2 and 3, as well as the highly homologous Gao, were all recruited to β- 
207
The interaction between Gai and β-arrestin was sensitive to pertussis toxin ( 
230
Given the paradoxical results of the Gas-coupled V2R catalyzing an unique Gai:β-arrestin complex,
231
we proceeded to investigate if this phenomenon was generalizable to other GPCRs that
232
canonically signal through different Ga proteins. We selected five well-studied GPCRs: the β2AR,
233
CXCR3, NT1R, D1R, and D2R. Of these, only CXCR3 and D2R canonically signal through Gai. The 234 β2AR and D1R canonically signal through Gas, and NT1R canonically signals through Gaq. All five 235 of these GPCRs formed Gai:β-arrestin complexes following agonist treatment (Figure 4 ). f, n=4 per condition. Graphs show mean ± s.e.m.
237
299
As described above it has long been clear that 
379
Split luciferase and complex BRET assays
380
HEK293T cells seeded in 6-well plates were co-transfected with 500 ng of smBiT tagged β- 
406
Immunoblotting
407
Experiments were conducted as previously described 28 . 
478
Immunoprecipitation
479
Immunoprecipitation was conducted as previously described 31 . Briefly, 4 µg of HA-V2R, 4 µg of 
513
Data availability
514
The data sets generated for this study are available from the corresponding author upon 515 reasonable request. All relevant data are included in the paper or the supplementary information.
517
Statistical analyses 518 Dose-response curves were fitted to a log agonist versus stimulus with three parameters (span,
519
baseline, and EC50) with the minimum baseline corrected to zero using Prism 8.0 (GraphPad,
520
San Diego, CA 
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